A feasibility study examining the biomarker associated with ovarian cancer [CA125] in women with and without ovarian cancer delivered encouraging results.

The global elahere market is set for rapid growth, projected to surge to $6.07 billion by 2034 at a CAGR of 28.68%. Key growth drivers include rising ovarian cancer prevalence, healthcare access ...

The race for early cancer detection is one that physicians have been running for millennia. In one of humanity’s oldest surviving medical texts, the ancient Egyptian physician Imhotep described ...

Ovarian cancer articles from across Nature Portfolio Ovarian cancer is an abnormal cell growth (tumour) arising in the ovary. The majority of ovarian cancers are epithelial and develop in women ...

Paula Radcliffe reveals symptoms she ignored before daughter’s cancer diagnosis Marathon runner said it was ‘easy’ to overlook the warning signs ...